Indeed, you give an honest warning Badger. Increased support in the following study regarding these significant risks with yet again rushed products with these anti-virals. It has the scientific community, yet again, divided with ethical scientists recognizing and vocalizing their concerns.
“The concern with Merck’s pill is that it works by inhibiting SARS-CoV-2 replication through viral mutagenesis, and some scientists have raised serious reservations about that mechanism of action.
FDA’s Antimicrobial Drugs Advisory Committee
narrowly voted 13-10 last month in favor of the pill’s benefits outweighing the risks for adults within 5 days of developing COVID-19 symptoms.
“Committee members who voted ‘No’ cited the following as reasons for concluding that the overall benefit-risk ratio was unfavorable: 1) a high number-needed-to-treat compared with placebo, 2) unclear efficacy against the Delta variant,
3) potential to drive viral mutations, and 4) mutagenicity risks,” according to a
summary of the meeting.”
www.science.org